BIOMAT Database Logo BIOMAT Database Logo

Mycophenolate mofetil and reduction in cyclosporine dosage for chronic renal allograft dysfunction. 1998

M S Islam, and G C Francos, and S R Dunn, and J F Burke
Division of Nephrology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009173 Mycophenolic Acid Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. Cellcept,Mycophenolate Mofetil,Mycophenolate Mofetil Hydrochloride,Mycophenolate Sodium,Mycophenolic Acid Morpholinoethyl Ester,Myfortic,RS 61443,RS-61443,Sodium Mycophenolate,Mofetil Hydrochloride, Mycophenolate,Mofetil, Mycophenolate,Mycophenolate, Sodium,RS61443
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M S Islam, and G C Francos, and S R Dunn, and J F Burke
Chronic renal allograft dysfunction: a role for mycophenolate mofetil?
April 2000, Transplantation,
M S Islam, and G C Francos, and S R Dunn, and J F Burke
Chronic allograft nephropathy: effect of cyclosporine reduction and addition of mycophenolate mofetil on progression of renal disease.
January 1999, Transplantation proceedings,
M S Islam, and G C Francos, and S R Dunn, and J F Burke
Mycophenolate mofetil in ongoing chronic kidney allograft dysfunction.
December 1998, Transplantation proceedings,
M S Islam, and G C Francos, and S R Dunn, and J F Burke
Mycophenolate mofetil substitution for cyclosporine a in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study.
February 2005, Transplantation,
M S Islam, and G C Francos, and S R Dunn, and J F Burke
Low-dose cyclosporine and mycophenolate mofetil in renal allograft recipients with suboptimal renal function.
December 1998, Transplantation,
M S Islam, and G C Francos, and S R Dunn, and J F Burke
Mycophenolate mofetil decreases the risk for chronic renal allograft failure.
January 2001, Transplantation proceedings,
M S Islam, and G C Francos, and S R Dunn, and J F Burke
Chronic renal allograft rejection: no response to mycophenolate mofetil.
August 1998, Transplantation,
M S Islam, and G C Francos, and S R Dunn, and J F Burke
Improvement of chronic renal failure after introduction of mycophenolate mofetil and reduction of cyclosporine dose.
February 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
M S Islam, and G C Francos, and S R Dunn, and J F Burke
Chronic allograft nephropathy and mycophenolate mofetil introduction in paediatric renal recipients.
November 2005, Pediatric nephrology (Berlin, Germany),
M S Islam, and G C Francos, and S R Dunn, and J F Burke
Mycophenolate mofetil in combination with reduction of calcineurin inhibitors for chronic renal dysfunction after liver transplantation.
December 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society,
Copied contents to your clipboard!